3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
25
Burkitt Lymphoma
15
Sarcoma
14
Lymphoma, Follicular
12
Neoplasms
11
Lymphoma
11
Hodgkin Disease
10
Breast Neoplasms
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, Non-Hodgkin
9
Triple Negative Breast Neoplasms
8
Ovarian Neoplasms
8
Endometrial Neoplasms
8
Lymphoma, B-Cell
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Recurrence
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasm Metastasis
5
Fallopian Tube Neoplasms
5
Wilms Tumor
4
Osteosarcoma
4
Lymphoma, Mantle-Cell
4
Liposarcoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Biphenotypic, Acute
4
Sarcoma, Ewing
3
Neuroblastoma
3
Lymphoproliferative Disorders
3
Lymphoma, T-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Interventions
Magnetic Resonance Spectroscopy
9
Specimen Handling
7
X-Rays
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
5
Temozolomide
4
Biopsy
4
Vincristine
3
Cyclophosphamide
3
Cisplatin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
pembrolizumab
2
palbociclib
2
olaparib
2
lutetium Lu 177 dotatate
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Radiotherapy
2
Radiation
2
Platinum
2
Lomustine
2
LY3023414
2
Diphtheria-Tetanus Vaccine
2
1,2-diaminocyclohexaneplatinum II citrate
2
sodium thiosulfate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Medulloblastoma
×
Doxorubicin
×
90 days
×
Clear all
No trials found.